Stocks and Investing
Stocks and Investing
Fri, March 26, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 25, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Walsh Initiated (VOR) at Strong Buy and Held Target at $60 on, Mar 25th, 2021
Justin Walsh of B. Riley Securities, Initiated "Vor Biopharma Inc." (VOR) at Strong Buy and Held Target at $60 on, Mar 25th, 2021.
Justin has made no other calls on VOR in the last 4 months.
There are 4 other peers that have a rating on VOR. Out of the 4 peers that are also analyzing VOR, 0 agree with Justin's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Justin
- Carter Gould of "Barclays" Initiated at Buy and Held Target at $56 on, Wednesday, March 3rd, 2021
- Umer Raffat of "Evercore ISI Group" Initiated at Buy and Held Target at $48 on, Wednesday, March 3rd, 2021
- Graig Suvannavejh of "Goldman Sachs" Initiated at Strong Sell and Held Target at $19 on, Tuesday, March 2nd, 2021
- Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $58 on, Tuesday, March 2nd, 2021
Contributing Sources